"Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients

Surgery

Volumn 142, Issue 6, 2007, Pages 900-905.e1

  Mitchell, Ian C ^a   Auchus, Richard J ^a   Juneja, Kavita ^a   Chang, Alice Y ^a   Holt, Shelby A ^a   Snyder III, William H ^a   Nwariaku, Fiemu E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADRENALECTOMY; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FACIAL PLETHORA; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; SKIN BRUISING; SKIN DISEASE; SKIN REDNESS; SKIN THINNING; WEIGHT GAIN;

EID: 36549012640     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.10.001     Document Type: Article

References (25)

1. Boscaro M., Barzon L., Fallo F., and Sonino N. Cushing's syndrome. Lancet 357 (2001) 783-791
2. Newell-Price J., Bertagna X., Grossman A.B., and Nieman L.K. Cushing's syndrome. Lancet 367 (2006) 1605-1617
3. Ross E.J., and Linch D.C. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2 (1982) 646-649
4. Etxabe J., and Vazquez J.A. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 40 (1994) 479-484
5. Catargi B., Rigalleau V., Poussin A., Ronci-Chaix N., Bex V., Vergnot V., et al. Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 88 (2003) 5808-5813
6. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism 28 (1979) 955-977
7. Invitti C., Pecori Giraldi F., de Martin M., and Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84 (1999) 440-448
8. Lin C.L., Wu T.J., Machacek D.A., Jiang N.S., and Kao P.C. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 82 (1997) 151-155
9. Findling J.W., Raff H., and Aron D.C. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab 89 (2004) 1222-1226
10. Wood P.J., Barth J.H., Freedman D.B., Perry L., and Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34 (1997) 222-229
11. Barzon L., Sonino N., Fallo F., Palu G., and Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149 (2003) 273-285
12. Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., Alì A., et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85 (2000) 637-644
13. Findling J.W., and Raff H. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 30 (2001) 729-747
14. Young Jr. W.F. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356 (2007) 601-610
15. Grumbach M.M., Biller B.M., Braunstein G.D., Campbell K.K., Carney J.A., Godley P.A., et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 138 (2003) 424-429
16. Trainer P.J., and Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 34 (1991) 317-330
17. Valli N., Catargi B., Ronci N., Vergnot V., Leccia F., Ferriere J.M., et al. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 144 (2001) 401-408
18. Reincke M., Nieke J., Krestin G.P., Saeger W., Allolio B., and Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75 (1992) 826-832
19. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29 (2000) 43-56
20. Tsagarakis S., Roboti C., Kokkoris P., Vasiliou V., Alevizaki C., and Thalassinos N. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol (Oxf) 49 (1998) 165-171
21. Emral R., Uysal A.R., Asik M., Gullu S., Corapcioglu D., Tonyukuk V., et al. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J 50 (2003) 399-408
22. Rossi R., Tauchmanova L., Luciano A., Di Martino M., Battista C., Del Viscovo L., et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85 (2000) 1440-1448
23. Bernini G., Moretti A., Iacconi P., Miccoli P., Nami R., Lucani B., et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148 (2003) 213-219
24. Tauchmanova L., Rossi R., Biondi B., Pulcrano M., Nuzzo V., Palmieri E.A., et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87 (2002) 4872-4878
25. Erbil Y., Ademoglu E., Ozbey N., Barbaros U., Yanik B.T., Salmaslioǧlu A., et al. Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg 30 (2006) 1665-1671